Question 1

Who are the top researchers at Affimed Therapeutics (Germany)?

Accepted Answer

Ranked on the quality score, Jens H. W. Pahl, Gabriele Hintzen and Eugene A. Zhukovsky lead among researchers whose main affiliation is Affimed Therapeutics (Germany).

Question 2

What are the most cited papers from Affimed Therapeutics (Germany)?

Accepted Answer

The most cited paper from Affimed Therapeutics (Germany) is "Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma" (Christopher James Gibson et al., 2017), with 483 citations. Next come "A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma" (336) and "A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+tumor cells" (162).

Question 3

Which research topics does Affimed Therapeutics (Germany) publish most on?

Accepted Answer

By volume in 2022-now: CAR-T cell therapy research, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research and T-cell and B-cell Immunology.

Question 4

Which keywords describe research at Affimed Therapeutics (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer Immunotherapy, Lymphoma and Immunotherapy.

Question 5

Which fields of science does Affimed Therapeutics (Germany) work in?

Accepted Answer

In all years, 62% of research at Affimed Therapeutics (Germany) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (62%), Immunology and Microbiology (19%), Biochemistry, Genetics and Molecular Biology (16%). It does 2.5× the world's share of Health Sciences.

Question 6

Is Affimed Therapeutics (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 4% lower than in 2018-2021.